<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02937688</url>
  </required_header>
  <id_info>
    <org_study_id>1678</org_study_id>
    <nct_id>NCT02937688</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation (DBS) for Parkinson's Disease International Study</brief_title>
  <acronym>REACH-PD</acronym>
  <official_title>Deep Brain Stimulation (DBS) for Parkinson's Disease International Study (REACH-PD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To gather data on DBS Therapy effectiveness in different geographic populations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective open label post market study of DBS for PD is to gather data&#xD;
      on DBS therapy effectiveness as measured by clinician and patient reported health outcomes&#xD;
      data through one year of follow-up in different geographic populations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 26, 2017</start_date>
  <completion_date type="Actual">July 30, 2021</completion_date>
  <primary_completion_date type="Actual">July 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Parkinson's disease-related quality of life, as measured by the Parkinson's Disease Questionnaire (PDQ-8).</measure>
    <time_frame>Baseline to 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in motor score, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS) III, off medication</measure>
    <time_frame>Baseline to 12 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">217</enrollment>
  <condition>Parkinson Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic DBS Therapy for Parkinson's disease</intervention_name>
    <description>Bilateral Deep Brain Stimulation (DBS) of the Subthalamic Nucleus or Globus Pallidus interna.</description>
    <other_name>Medtronic Activa DBS System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with levodopa responsive Parkinson's disease that are not adequately controlled&#xD;
        by medication.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Indication of DBS for PD consistent with the country specific approved labeling.&#xD;
&#xD;
          2. Levodopa-responsive Parkinson's disease (UPDRS III ≥ 30% improvement on Levodopa&#xD;
             challenge test).&#xD;
&#xD;
          3. Symptoms treatable by medications but not adequately controlled with medications (with&#xD;
             persistent disabling symptoms, such as motor fluctuations, dyskinesia).&#xD;
&#xD;
          4. At least 22 years old.&#xD;
&#xD;
          5. Screening cranial MRI, performed within 12 months of entry into the study, that is&#xD;
             normal or with a non-significant abnormality that does not present any incremental&#xD;
             risks or concerns for the patient as a result of the DBS procedure.&#xD;
&#xD;
          6. Understand potential risk/benefit, consent to the study, study procedures, and agree&#xD;
             to complete the study follow-up visits and comply with the study protocol&#xD;
             requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Secondary Parkinson's disease, atypical syndromes.&#xD;
&#xD;
          2. Previous stereotactic functional neurosurgery or ablative therapy (e.g., pallidotomy,&#xD;
             subthalamotomy), surgical contraindications related to DBS.&#xD;
&#xD;
          3. Dementia (Mattis Dementia Rating Scale ≤ 130), major depression with suicidal thoughts&#xD;
             (Beck Depression Inventory II &gt; 25), acute psychosis, active alcohol or drug abuse,&#xD;
             terminal illness, and any major medical or psychological histories, diagnoses,&#xD;
             conditions, or comorbidities that would interfere with participation in the study per&#xD;
             the investigator's medical judgment.&#xD;
&#xD;
          4. Electrical or electromagnetic implant (e.g., Cochlear prosthesis, cardiac pacemaker).&#xD;
&#xD;
          5. Surgical or medical contraindications to DBS surgery or therapy (e.g., uncontrolled&#xD;
             hypertension, advanced coronary artery disease).&#xD;
&#xD;
          6. Participation in a drug, device, or biologics trial within the preceding 30 days that&#xD;
             may confound the study results.&#xD;
&#xD;
          7. Pregnant female.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitário Cajuru</name>
      <address>
        <city>Curitiba</city>
        <state>Parana</state>
        <zip>80050-350</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Belo Horizonte</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Rafael - Monte Tabor</name>
      <address>
        <city>Salvador</city>
        <zip>41253-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clinicas de Sao Paulo/ IPQ</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01060-970</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Base de São Jose do Rio Preto</name>
      <address>
        <city>São José do Rio Preto</city>
        <zip>15090-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPDM- Hospital Sao Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04037-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Marcelina</name>
      <address>
        <city>São Paulo</city>
        <zip>08270-070</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuanwu Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huaxi Hospital</name>
      <address>
        <city>Chengdu</city>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2016</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

